Skip to main content
Steven Fishbane, MD, Nephrology, Manhasset, NY, Long Island Jewish Medical Center

StevenFishbaneMD

Nephrology Manhasset, NY

Professor, Medicine, Hofstra North Shore-LIJ

Dr. Fishbane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fishbane's full profile

Already have an account?

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Nephrology, 1991 - 1993
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1989 - 1991
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Internship, Internal Medicine, 1988 - 1989
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1988

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1990 - 2025
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Administrative Leadership: Nephrologists in Non-Nephrology Leadership Roles  
    Michael Gitman, Alessandro Bellucci, Steven Fishbane, Advances in Chronic Kidney Disease

Lectures

  • A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/10/2019
  • Intravenous Epoetin Alfa-Epbx Versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Authored Content

  • A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with PruritusJanuary 2020

Press Mentions

  • Northwell Announces $1.25M Endowed, First-of-Its-Kind Kidney Fellowship
    Northwell Announces $1.25M Endowed, First-of-Its-Kind Kidney FellowshipJuly 20th, 2022
  • Common Gene Variant May Predict Peritoneal Dialysis Outcomes
    Common Gene Variant May Predict Peritoneal Dialysis OutcomesOctober 20th, 2021
  • FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting
    FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual MeetingDecember 2nd, 2020
  • Join now to see all

Hospital Affiliations